Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|June 2, 2018
Chromatin Immunoprecipitation for Identification of Protein-DNA Interactions in Human CellsBjørk Ditlev Larsen, Martin Rønn Madsen, Ronni Nielsen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 1, 2024
Improvement of NASH and liver fibrosis through modulation of the gut-liver axis by a novel intestinal FXR agonistAn-Na Moon, François Briand, Natalia Breyner, et al.
Gut|August 13, 2025
Mucosal transcriptomic landscape along the small and large intestines in individuals with and without type 2 diabetesHannah Gilliam-Vigh, Anne Marie Ellegaard, Martin Rønn Madsen, et al.
BMC Gastroenterology|February 2, 2024
Dietary intervention reverses molecular markers of hepatocellular senescence in the GAN diet-induced obese and biopsy-confirmed mouse model of NASHMathias Flensted-Jensen, Denise Oró, Emma A Rørbeck, et al.
Biomedicines|July 27, 2022
Nephroprotective Effects of Semaglutide as Mono- and Combination Treatment with Lisinopril in a Mouse Model of Hypertension-Accelerated Diabetic Kidney DiseaseLouise S Dalbøge, Michael Christensen, Martin Rønn Madsen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 10, 2020
Characterization of local gut microbiome and intestinal transcriptome responses to rosiglitazone treatment in diabetic db/db miceMette Simone Aae Madsen, Rikke Veggerby Grønlund, John Eid, et al.
Molecular Metabolism|March 1, 2024
Atlas of exercise-induced brain activation in miceGrethe Skovbjerg, Andreas Mæchel Fritzen, Charlotte Sashi Aier Svendsen, et al.
Scientific Reports|December 28, 2023
Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosisHenrik H Hansen, Susanne Pors, Maja W Andersen, et al.
Clinical and Translational Science|February 10, 2022
Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet-induced obese and biopsy-confirmed mouse model of NASHMathias B Møllerhøj, Sanne S Veidal, Kirstine Tølbøl Thrane, et al.
Physiological Reports|October 11, 2024
Reproducible lung protective effects of a TGFβR1/ALK5 inhibitor in a bleomycin-induced and spirometry-confirmed model of IPF in male miceAsbjørn Graver Petersen, Stefanie H Korntner, Jamal Bousamaki, et al.
Pageof 2